Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 15, 2012 (Vol. 32, No. 20)

Metabolic & Genetic Information Center

  • Can browse by disease name or symptoms
  • Last updated in 2010

The human body is an amazing metabolic machine—thousands of enzymes catalyze an equivalent (and impressive) number of chemical reactions that allow the body to run properly. This complexity also means that there are many ways that things can go wrong. The Metabolic and Genetic Information Center, a site hosted by the School of Medicine at the University of Tuebingen, Germany, catalogs a large number of genetic disorders that result in defective metabolism. One can browse the database by disease name or symptoms. For each disease, the website lists clinical symptoms, incidence rate, treatment and other basic information; however, the main focus of the database is to provide links to relevant literature on PubMed. To that end, visitors to the site can also search the catalogued references by author. Unfortunately, while this site is definitely still a useful resource on the topic of genetic diseases, the last update was in 2010. As such, there are no literature citations more recent than that year.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »